- Trials with a EudraCT protocol (300)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
300 result(s) found for: Antipsychotic.
Displaying page 1 of 15.
EudraCT Number: 2020-000053-27 | Sponsor Protocol Number: MELIA | Start Date*: 2020-07-09 |
Sponsor Name:UMC Utrecht | ||
Full Title: The MEtformin-LIfestyle in Antipsychotic users trial (MELIA): optimizing the use of metformin in the management of antipsychotic-induced weight gain. | ||
Medical condition: Antipsychotic-induced weight gain (AiWG) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000338-37 | Sponsor Protocol Number: 1723/1-1 | Start Date*: 2014-11-04 | ||||||||||||||||
Sponsor Name:Technische Universität München, vertreten durch das Klinikum rechts der Isar | ||||||||||||||||||
Full Title: Evaluation of the necessity of a pharmacological treatment with antipsychotics for the prevention of relapse in long-term stabilized schizophrenic patients: a randomized, single-blind, longitudinal... | ||||||||||||||||||
Medical condition: schizophrenia or schizoaffective disorder in remission for at least 3 years under a stable antipsychotic medication. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003434-24 | Sponsor Protocol Number: ACP-103-034 | Start Date*: 2017-04-28 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) CZ (Completed) LT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005451-42 | Sponsor Protocol Number: DISCAP | Start Date*: 2009-01-13 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Long-term use of antipsychotics for behavioral symptoms in patients with mental retardation; a controlled discontinuation study | ||
Medical condition: Mental retardation | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005404-17 | Sponsor Protocol Number: TAO-EX-2012 | Start Date*: 2013-01-16 |
Sponsor Name:Center for Neuropsychiatric Schizophrenia Research | ||
Full Title: Treatment of antipsychotic associated obesity with a GLP-1 Analogue: the TAO study | ||
Medical condition: Obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019897-33 | Sponsor Protocol Number: 2522518514 | Start Date*: 2011-04-14 |
Sponsor Name:erasmus mc | ||
Full Title: Selective D1 activation by addition of L-Dopa to antipsychotic treatment in patients with schizophrenia | ||
Medical condition: patients with psychotic symptoms, diagnosed with schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-018022-30 | Sponsor Protocol Number: R092670SCH3010 | Start Date*: 2010-11-05 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A 6-month, open label, prospective, multicenter, international, exploratory study of a transition to flexibly dosed paliperidone palmitate in patients with schizophrenia previously unsuccessfully ... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) HU (Completed) DE (Completed) NL (Completed) BE (Completed) ES (Completed) GB (Completed) SE (Completed) DK (Completed) IT (Completed) LV (Completed) AT (Completed) EE (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001661-41 | Sponsor Protocol Number: Ser01 | Start Date*: 2006-06-08 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Body Composition and Metabolic Changes During Antipsychotic Treatment. A Randomized Trial Comparing Sertindole and Olanzapine. | ||
Medical condition: Patients with schizophrenia diagnosis (DSM-IV) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000180-28 | Sponsor Protocol Number: GWMD09126 | Start Date*: 2011-07-12 | ||||||||||||||||
Sponsor Name:GW Pharma Ltd | ||||||||||||||||||
Full Title: A randomised, double-blind, placebo-controlled parallel group, pilot study of 40:1 ratio of formulated GWP42003 : GWP42004 in the treatment of iatrogenic weight gain and dyslipidaemia associated wi... | ||||||||||||||||||
Medical condition: Iatrogenic weight gain and dyslipidaemia associated with treatment using antipsychotic medication | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003437-18 | Sponsor Protocol Number: ACP-103-039 | Start Date*: 2017-10-05 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (Enhance-2) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005839-10 | Sponsor Protocol Number: D1449L00016 | Start Date*: 2007-08-24 |
Sponsor Name:Georg-August-University Göttingen | ||
Full Title: Efficacy and safety of quetiapine in treating affective symptoms of patients with first-episode psychosis - a pilot study | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005726-29 | Sponsor Protocol Number: CariCog | Start Date*: 2021-02-23 |
Sponsor Name:Medical University Innsbruck | ||
Full Title: An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000913-21 | Sponsor Protocol Number: D1444C00147 | Start Date*: 2004-10-05 |
Sponsor Name:AstraZeneca R&D Södertälje | ||
Full Title: A 12-week International, Multicenter, Open Label, Non-comparative Study to Evaluate the Feasibility of Switching any Antipsychotic Treatment to Sustained-release Quetiapine Fumarate (SEROQUEL) in P... | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) HU (Completed) LV (Completed) EE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002406-12 | Sponsor Protocol Number: NL6220204217 | Start Date*: 2019-04-04 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medicati... | ||
Medical condition: HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose ... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003284-11 | Sponsor Protocol Number: 16159B | Start Date*: 2016-09-22 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Interventional, open-label, flexible-dose, long-term safety study of Lu AF35700 in adult patients with schizophrenia | |||||||||||||
Medical condition: Treatment-resistant schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) SK (Completed) EE (Completed) FI (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002960-85 | Sponsor Protocol Number: NN20372 | Start Date*: 2008-03-18 | |||||||||||
Sponsor Name:F.Hoffmann-La Roche Ltd | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled add-on trial of the safety and efficacy of RO4917838 in outpatients on select atypical antipsychotics with prominent negative or disorganized thought sy... | |||||||||||||
Medical condition: Schizophrenia - This study will be conducted to investigate whether or not administration of RO4917838 along with their current antipsychotic regimen to stable patients can lead to further improvem... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FR (Completed) AT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002369-23 | Sponsor Protocol Number: 1289-0049 | Start Date*: 2019-05-27 | |||||||||||
Sponsor Name:Boehringer Ingelheim | |||||||||||||
Full Title: A phase II randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered BI 409306 during a 28-week treatment period as adjunctive the... | |||||||||||||
Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011228-73 | Sponsor Protocol Number: OCTUMI-03 | Start Date*: 2010-02-09 | |||||||||||
Sponsor Name:University of Oxford [...] | |||||||||||||
Full Title: A pilot study of Aripiprazole treatment for antipsychotic induced hyperprolactinaemia in young patients with severe mental illness and learning disabilities. | |||||||||||||
Medical condition: Antipsychotic induced hyperprolactinaemia | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003369-16 | Sponsor Protocol Number: GWAP19030 | Start Date*: 2020-06-02 |
Sponsor Name:GW Research Ltd. | ||
Full Title: A Randomized, Double-blind, Parallel-group Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants with Schizophrenia Experiencing Inadequate... | ||
Medical condition: Schizophrenia is neurodevelopmental syndrome, results from gradual alterations in brain connectivity. Can persist for years before psychosis emerges. Individuals have a 2 to 3 fold increased risk o... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) PL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-004972-11 | Sponsor Protocol Number: S154.3.020 | Start Date*: 2007-04-11 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals Inc | |||||||||||||
Full Title: A multi-center, open-label, parallel-group, randomized, flexible dose study to evaluate the safety and tolerability of switching from existing atypical antipsychotics to bifeprunox in subjects with... | |||||||||||||
Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) LT (Prematurely Ended) EE (Prematurely Ended) LV (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.